Filing Flows › Syra Health (SYRA) › Q3 2026 › vs Q2 2026
Syra Health (SYRA) Q3 2026 vs Q2 2026 (quarter over quarter)
Syra Health's revenue rose $163K (+7%) from $2.4M in Q2 2026 to $2.6M in Q3 2026. The biggest changes: Population Health +$227K (+13%); Healthcare Workforce −$65K (-10%). Gross margin 46.3% against 44.5% (+1.8 pts).
Syra Health, Q3 2026: revenue $2.6M (+52% year over year), operating margin 11.7%, net earnings $345K, operating cash flow $332K. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Gross margin | 46.3% | 44.5% | +1.8 pts |
| Operating margin | 11.7% | 10.5% | +1.2 pts |
| Net margin | 13.5% | 10.5% | +3.0 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Population Health | $1.9M | $1.7M | $227K | +13% |
| Healthcare Workforce | $614K | $678K | −$65K | -10% |
| Revenue | $2.6M | $2.4M | $163K | +7% |
| Gross profit | $1.2M | $1.1M | $119K | +11% |
| Cost of revenue | $1.4M | $1.3M | $44K | +3% |
| Operating profit | $300K | $252K | $48K | +19% |
| Operating expenses | $885K | $815K | $70K | +9% |
| Pre-tax earnings | $300K | $250K | $49K | +20% |
| Research & development | $47K | $47K | −$1K | -1% |
| SG&A | $222K | $236K | −$14K | -6% |
| Other operating costs | $616K | $531K | $85K | +16% |
| Income tax benefit | $45K | $0 | $45K | — |
| Net earnings | $345K | $250K | $94K | +38% |
| Depreciation | $1K | $1K | −$26 | -4% |
| Share-based compensation | $45K | $21K | $24K | +114% |
| Working capital & other | $59K | $991K | −$932K | -94% |
| Operating cash flow | $332K | −$719K | $1.1M | — |
Questions
How much did Syra Health's revenue grow quarter over quarter in Q3 2026?
Syra Health's revenue rose $163K (+7%) from $2.4M in Q2 2026 to $2.6M in Q3 2026.
What drove Syra Health's revenue change in Q3 2026?
Population Health +$227K (+13%); Healthcare Workforce −$65K (-10%).